Work

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial

Year: 2009

Type: article

Study design: Study Protocol

Source: American Heart Journal

DOI: 10.1016/j.ahj.2009.06.027

Authors: David A. Morrow, Benjamin M. Scirica, Keith A.A. Fox, Gail Berman, John Strony, Enrico Veltri, Marc P. Bonaca, Polly Fish, Carolyn H. McCabe, Eugene Braunwald

Institutions: Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group, University of Edinburgh

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1999756278

FWCI: 21.79

Cites: 19

Cited by: 171

Related to: 10